These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
402 related articles for article (PubMed ID: 12540027)
1. Complications of hepatic artery infusion: a review of 4580 reported cases. Barnett KT; Malafa MP Int J Gastrointest Cancer; 2001; 30(3):147-60. PubMed ID: 12540027 [TBL] [Abstract][Full Text] [Related]
2. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Link KH; Kornmann M; Leder G; Pillasch AF; Sunelaitis E; Schatz M; Pressmar J; Beger HG Gan To Kagaku Ryoho; 1999 Feb; 26(3):269-81. PubMed ID: 10065089 [TBL] [Abstract][Full Text] [Related]
3. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. ; Piedbois P; Buyse M; Kemeny N; Rougier P; Carlson R; Allen-Mersh T; O'Connell M; Chang A; Sondak V; Kemeny M; Levy E J Natl Cancer Inst; 1996 Mar; 88(5):252-8. PubMed ID: 8614003 [TBL] [Abstract][Full Text] [Related]
4. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. Lorenz M; Müller HH J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236 [TBL] [Abstract][Full Text] [Related]
5. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951 [TBL] [Abstract][Full Text] [Related]
6. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. Rougier P; Laplanche A; Huguier M; Hay JM; Ollivier JM; Escat J; Salmon R; Julien M; Roullet Audy JC; Gallot D J Clin Oncol; 1992 Jul; 10(7):1112-8. PubMed ID: 1296590 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336 [TBL] [Abstract][Full Text] [Related]
8. Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the liver at the lahey clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement. Oberfield RA; Sampson E; Heatley GJ Am J Clin Oncol; 2004 Aug; 27(4):376-83. PubMed ID: 15289731 [TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU. Schlag P; Hohenberger P; Hölting T; Buhl K; Schwarz V; Herfarth C Eur J Surg Oncol; 1990 Apr; 16(2):99-104. PubMed ID: 2323413 [TBL] [Abstract][Full Text] [Related]
10. [Complication due to arterial infusion chemotherapy for liver metastasis from colorectal cancer]. Tsuji Y; Hamada H; Katsuki Y; Hashimoto M; Tomita I; Kon H; Sasaki R; Kawata S; Yasuda T Gan To Kagaku Ryoho; 1997 Sep; 24(12):1838-42. PubMed ID: 9382546 [TBL] [Abstract][Full Text] [Related]
12. Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. Mocellin S; Pasquali S; Nitti D Cochrane Database Syst Rev; 2009 Jul; (3):CD007823. PubMed ID: 19588444 [TBL] [Abstract][Full Text] [Related]
13. Intra-arterial hepatic chemotherapy (IAHC) for liver metastases from colorectal cancer: need of guidelines for catheter positioning, port management, and anti-coagulant therapy. Fiorentini G; De Giorgi U; Giovanis P; Guadagni S; Cantore M; Marangolo M; Ann Oncol; 2001 Jul; 12(7):1023. PubMed ID: 11521788 [No Abstract] [Full Text] [Related]
14. Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer. Whisenant J; Venook A Oncology (Williston Park); 2004 May; 18(6):762-8; discussion 769-73. PubMed ID: 15214595 [TBL] [Abstract][Full Text] [Related]
15. Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases. Zanon C; Grosso M; Clara R; Alabiso O; Chiappino I; Miraglia S; Martinotti R; Bortolini M; Rizzo M; Gazzera C Am J Clin Oncol; 2001 Aug; 24(4):354-9. PubMed ID: 11474260 [TBL] [Abstract][Full Text] [Related]
16. [The role of prophylactic hepatic arterial infusion chemotherapy after potentially curative resection of hepatic metastases from colorectal cancer]. Tono T; Monden T Nihon Geka Gakkai Zasshi; 2000 Aug; 101(8):568-73. PubMed ID: 10976444 [TBL] [Abstract][Full Text] [Related]
17. Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized study. Fiorentini G; Cantore M; Rossi S; Vaira M; Tumolo S; Dentico P; Mambrini A; Bernardeschi P; Turrisi G; Giovanis P; Guadagni S; Valori V; De Simone M In Vivo; 2006; 20(6A):707-9. PubMed ID: 17203750 [TBL] [Abstract][Full Text] [Related]
18. [Complications of hepatic artery chemotherapy for liver metastases in colorectal cancer]. Maruyama S Nihon Rinsho; 2003 Sep; 61 Suppl 7():379-82. PubMed ID: 14574917 [No Abstract] [Full Text] [Related]
19. Selective intra-arterial chemotherapy with floxuridine as second- or third-line approach in patients with unresectable colorectal liver metastases. Samaras P; Breitenstein S; Haile SR; Stenner-Liewen F; Heinrich S; Feilchenfeldt J; Renner C; Knuth A; Pestalozzi BC; Clavien PA Ann Surg Oncol; 2011 Jul; 18(7):1924-31. PubMed ID: 21207165 [TBL] [Abstract][Full Text] [Related]